Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar <p>In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. <br></p><p><a href="http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar"><img src="http://biologictube.dk/10820443/11747483/56f6f45ae412228e1969e5c435f7b8a8/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/11747483 Thu, 09 Jul 2015 14:24:23 GMT Hvidovre Hospital - why we have implemented suPAR in clinical routine In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. Welcome to the BioLogicTube 01:35 <p>In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. <br></p><p><a href="http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar"><img src="http://biologictube.dk/10820443/11747483/56f6f45ae412228e1969e5c435f7b8a8/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> copenhagen university crp disease elderly hvidovre hospital immune activation inflammation prognosis prognostic risk risk recognition routine biomarker severe severity severity and prognosis. supar is a biomarker of disease presence triage virogates http://biologictube.dk/photo/6702449/supar-and-apache-ii-score-in-risk <p>Dr Evangelos Giamarellos-Bourboulis talks on the combined use of suPAR and APACHE II score in risk assesment in critically ill patients. The work by Giamarellos-Bourboulis and coworkes was published August 8th, 2012 in Critical Care and entitled "Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor" and can be read here <a href="http://ccforum.com/content/16/4/R149/abstract">http://ccforum.com/content/16/4/R149/abstract</a></p><p><a href="http://biologictube.dk/photo/6702449/supar-and-apache-ii-score-in-risk"><img src="http://biologictube.dk/4959050/6702449/31a1d1bc381b65e8a08cc37f808c0c16/standard/download-5-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/6702449 Tue, 14 Aug 2012 11:58:51 GMT suPAR and APACHE II score in risk assesment in critically ill patients by Dr... Dr Evangelos Giamarellos-Bourboulis talks on the combined use of suPAR and APACHE II score in risk assesment in critically ill patients. The work by Giamarellos-Bourboulis and coworkes was published August 8th, 2012 in Critical Care and entitled "Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor" and can be read here http://ccforum.com/content/16/4/R149/abstract Dr Evangelos Giamarellos-Bourboulis talks on the combined use of suPAR and APACHE II score in risk assesment in critically ill patients. The work by Giamarellos-Bourboulis and coworkes was published August 8th, 2012 in Critical Care and entitled... Welcome to the BioLogicTube 19:29 <p>Dr Evangelos Giamarellos-Bourboulis talks on the combined use of suPAR and APACHE II score in risk assesment in critically ill patients. The work by Giamarellos-Bourboulis and coworkes was published August 8th, 2012 in Critical Care and entitled "Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor" and can be read here <a href="http://ccforum.com/content/16/4/R149/abstract">http://ccforum.com/content/16/4/R149/abstract</a></p><p><a href="http://biologictube.dk/photo/6702449/supar-and-apache-ii-score-in-risk"><img src="http://biologictube.dk/4959050/6702449/31a1d1bc381b65e8a08cc37f808c0c16/standard/download-5-thumbnail.jpg" width="600" height="338"/></a></p> algorithm bacterial biomarkers care critical disease helenic infection prognosis prognostication sepsis severe supar suparnostic symposium viral virogates